The clinical efficacy of antihistamines in the skin

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 55, Issue 60, 2000, Pages 11-16

  Tharp, M D ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; CETIRIZINE; CHLORPHENIRAMINE; COLCHICINE; DAPSONE; EBASTINE; EPINASTINE; ERYTHROMYCIN; FEXOFENADINE; HYDROXYZINE; ITRACONAZOLE; KETOCONAZOLE; LEVOCABASTINE; LORATADINE; MIZOLASTINE; OXATOMIDE; PROMETHAZINE; QUININE; TERFENADINE;

ATOPIC DERMATITIS; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; DRUG CLASSIFICATION; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN ALLERGY; URTICARIA;

CHRONIC DISEASE; HISTAMINE H1 ANTAGONISTS; HUMANS; TREATMENT OUTCOME; URTICARIA;

EID: 0034026909     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. LESHER JL. Recent developments in antifungal therapy. Dermatol Clin 1996;14:163-169.
2. LEURS R, SMIT MJ, TIMMERMAN H. Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 1995;66:413-63.
3. GOLDSTEIN SM, THARP MD. Urticaria. In: ARNDT KA, LEBOLT PE, ROBINSON JK, WINTROUB BU, editors. Cutaneous medicine and surgery. Philadelphia: WB Saunders, 1992:392-406.
4. KALVIS J, BRENEMAN D, THARP MD, et al. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 1990;86:1014-1018.
5. MONROE EW, BERNSTEIN DI, FOX RW, et al. Relative efficacy and safety of loratadine, hydroxyzine and placebo in chronic idiopathic urticaria. Arzneimittelforschung 1992;421:1119-1I21.
6. 1 antagonist with anti-eosinophilic activity in chronic urticaria. J Am Acad Dermatol 1991;25:668-674.
7. MARKHAM A, WAGSTAFF AJ. Fexofenadine. Drugs 1998;55:269-274.
8. ZAVADEK D, THARP MD. Chronic urticaria as a manifestation of the late phase reaction. Immunol Allergy Clin North Am 1995;15:745-749.
9. BRENEMAN D, BRONSKY EA, BRUCE SB, et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995;33:192-198.
10. ANDRI L, SENNA GE, BETTELI C, GIVAVN S, ANDRI G. Comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. Allergy 1993;48:358-365.
11. GOH CL, WONG WK, LIM J. Cetirizine vs placebo in chronic idiopathic urticaria -a double blind randomised cross-over study. Ann Acad Med Singapore 1991;20:328-330.
12. KIETZMANN H, MACHER E, RIHOUX J-P, GHYS L. Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990;65:498-500.
13. KINT A, CONSTANDT L, ARENDT C, BERHEIM J. Comparative efficacy of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Acta Ther 1989;15:65-75.
14. SIMONS FER, KESSELMAN MS, GIDDINS NG, PELECH AN, SIMONS KJ. Astemizole-induced torsade de pointes. Lancet 1988;2:624.
15. DAVIES AJ, HARINDA V, MCEWAN A, GHOSE RR. Cardiotoxic effect with convulsions in terfenadine overdose. BMJ 1989;298:325.
16. 1-receptor antagonists in allergic disease. Clinical Allergy and Immunology Series. New York: Marcel Dekker, 1996;145-174.
17. WALSH GM. The effects of cetirizine on the function of inflammatory cells involved in the allergic response. Clin Exp Allergy 1997;27:47-53.
18. FADEL R, HEPRIN-RICHARD N, RIHOUX J-P, HINOCQ E. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1987;17:373-379.
19. FADEL R, DAVID B, HEPRIN-RICHARD N, BORGNON A, RASSEMONT R, RIHOUX J-P. IN vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet activating factor in man. J Allergy Clin Immunol 1990;86:314-320.
20. 1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992;262:964-970.
21. LEIFERMAN KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 1994;94:1310-1317.
22. HANNUKSELA M, KALIMO K, LAMMINTAUSTA K, et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 1993;70:127-133.
23. JUHLIN L, BAEKKEN T. Histamine-induced increase of basophil and eosinophil leukocytes in inflammatory exudates. Acta Derm Venereol 1965;45:349-354.
24. MELTZER E. Comparative safety of antihistamines. Ann Allergy 1991;67:625-633.
25. GRANT JA, DANIELSON L, RIHOUX J-P, DE VOS C. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. Allergy 1999;54:700-707.
26. TURNER CR, ANDERSEN CJ, SMITH WB, WATSON JW. Characterisation of a primate model of asthma using anti-allergy/anti-asthma agents. Inflamm Res 1996;45:239-245.
27. PASQUALE CP, DE SILVA PMR, LIMA MCR, et al. Suppression by cetirizine of pleurisy triggered by antigen in actively sensitised rats. Eur J Pharmacol 1992;223:9-14.
28. BANDEIRA-MELO C, DE SILVA PM, CORDEIRO RS, MARTINS MA. Pleural fluid eosinophils suppress local IgE-mediated protein exudation in rats. J Leukoc Biol 1995;58:395-402.
29. JOHNSON HG, MCNEE ML, NUGENT RA. Canine in vivo tracheal chemotaxis of eosinophils to antigen in sensitised dogs: inhibition by a steroid, a systemic lavaroid U-78517F, and several topical antihistamines. Am Rev Respir Dis 1992;146:621-625.
30. PICHAT P, ANGEL I, ARBILLA S. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat. Arzneimittelforschung 1998;48:173-178.
31. GOLDHILL J, PICHAT P, ROOME N, ANGEL I, ARBILLA S. Effect of mizolastine on visceral afferent sensitivity and inflammation during experimental colitis. Arzneimittelforschung Drug Res 1998;48:179-184.
32. VARGAFTIG BB. Mechanisms of experimental bronchopulmonary hyperresponsiveness as related to eosinophils. In: LANGER SZ, et al., editors. New developments in the therapy of allergic disorders and asthma. Int Acad Biomed Drug Res 1993;6:27-32.